Assistant Professor of Psychiatry, Center for Depression Research and Clinical Care UT Southwestern Medical Center UT Southwestern
While anxiety disorders affect 1 in 3 adults in the United States during their lifetime. Poor treatment outcomes can be attributed to suboptimal use of currently available treatment and treatment resistance in a sizeable minority of patients. This session will provide tools to the clinicians to improve outcomes of their patients by using the currently available treatments, both FDA approved indications as well as commonly used off-label ones, in an evidence-based fashion. Additionally, the landscape of treatment on the horizon will be surveyed to enable clinicians to discuss these with their patients.